- Home
- VBF vs DERM Comparison
VBF vs DERM Comparison
Compare VBF & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.29
Company Overview
Basic Information| Metric | VBF | DERM |
|---|---|---|
| Founded | 1970 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.5M | 213.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | VBF | DERM |
|---|---|---|
| Price | $15.48 | $8.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.67 |
| AVG Volume (30 Days) | 45.5K | ★ 198.3K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 5.18% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $59,399,000.00 |
| Revenue This Year | N/A | $18.34 |
| Revenue Next Year | N/A | $54.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.82 |
| 52 Week Low | $13.68 | $3.54 |
| 52 Week High | $16.27 | $9.40 |
Technical Indicators
Market Signals| Indicator | VBF | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 54.91 |
| Support Level | $15.53 | $7.27 |
| Resistance Level | $15.63 | $8.16 |
| Average True Range (ATR) | 0.14 | 0.42 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 19.05 | 73.41 |
Price Performance
Historical Comparison VBF
DERM
About VBF Invesco Bond Fund
Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.